Ardelyx (ARDX) EBITDA Margin (2013 - 2026)
Ardelyx posted quarterly EBITDA Margin of 40.15% for Q1 2026, up 1542.0% year-on-year from 2.44% in Q1 2025, and down 14995.69% on a QoQ basis from 0.27% in Q4 2025.
Ardelyx (ARDX) has 12 years of EBITDA Margin data on file, last reported at 40.15% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 1542.0% year-over-year to 40.15%; the trailing twelve-month figure through Mar 2026 stood at 18.15% (down 329.0% YoY), and the FY2025 full-year result was 15.09%, down 331.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 40.15%, down from 0.27% in the prior quarter.
- Across five years, EBITDA Margin topped out at 24.34% in Q4 2022 and bottomed at 6015.6% in Q1 2022.
- The 5-year median for EBITDA Margin is 40.15% (2026), against an average of 477.53%.
- The widest annual swing landed in 2022, when EBITDA Margin slumped 551183 bps; it then surged 578041 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 24.34% in 2022, then tumbled by 439 bps to 82.58% in 2023, then jumped by 105 bps to 3.89% in 2024, then plunged by 107 bps to 0.27% in 2025, then sank by 14996 bps to 40.15% in 2026.
- The last three EBITDA Margin figures came in at 40.15% (Q1 2026), 0.27% (Q4 2025), and 23.74% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.24% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -40.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.15% |
| Dec 31, 2025 | -0.27% |
| Sep 30, 2025 | -23.74% |
| Jun 30, 2025 | -19.59% |
| Mar 31, 2025 | -55.57% |
| Dec 31, 2024 | 3.89% |
| Sep 30, 2024 | -0.53% |
| Jun 30, 2024 | -22.58% |
| Mar 31, 2024 | -58.15% |
| Dec 31, 2023 | -82.58% |
| Sep 30, 2023 | 11.77% |
| Jun 30, 2023 | -77.51% |
| Mar 31, 2023 | -235.19% |
| Dec 31, 2022 | 24.34% |
| Sep 30, 2022 | -459.25% |
| Jun 30, 2022 | -1,067.26% |
| Mar 31, 2022 | -6,015.60% |
| Dec 31, 2021 | -3,522.16% |
| Sep 30, 2021 | -3,715.94% |
| Jun 30, 2021 | -3,440.82% |
| Mar 31, 2021 | -503.77% |
| Dec 31, 2020 | -1,601.44% |
| Sep 30, 2020 | -675.82% |
| Jun 30, 2020 | -1,339.60% |
| Mar 31, 2020 | -1,849.71% |
| Dec 31, 2019 | -878.84% |
| Sep 30, 2019 | -781.65% |
| Jun 30, 2019 | -141,461.11% |
| Dec 31, 2018 | -32,803.53% |
| Sep 30, 2018 | -14,015.70% |
| Jun 30, 2018 | -74,120.00% |
| Mar 31, 2018 | -735.47% |
| Jun 30, 2015 | 49.91% |
| Mar 31, 2015 | -59.32% |
| Dec 31, 2014 | -62.05% |
| Sep 30, 2014 | 1.07% |
| Jun 30, 2014 | 30.11% |
| Mar 31, 2014 | -5.43% |
| Dec 31, 2013 | -8.46% |
| Sep 30, 2013 | -13.44% |
| Jun 30, 2013 | -11.67% |